Clinical trial
Lamictal Bipolar Observational Study
NCT00460226 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00460226 |
|---|---|
| Title | Lamictal Bipolar Observational Study |
| Official title | A Multi-centre, Observational Study to Evaluate the Incidence of Non-serious Rash in Korean Bipolar I Patients With Lamotrigine Therapy in Real World Setting |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Bipolar Disorder |
| Intervention type | Drug |
| Interventions | lamotrigine |
| Enrollment | 238 |
| Start date | Mar 1, 2007 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Apr 13, 2007 |
| Last update posted | Mar 19, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: